Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor

被引：1
|
作者：
Ikeda, Shiyo [1 ,2 ]
Takahashi, Toshiya [1 ,2 ]
Tandoh, Toshitsugu [3 ]
Ushiyama, Kaori [2 ,4 ]
Kida, Yujiro [1 ,2 ]
机构：
[1] Takashimadaira Chuo Gen Hosp, Dept Nephrol, Tokyo, Japan
[2] Takashimadaira Chuo Gen Hosp, Blood Purificat Ctr, Tokyo, Japan
[3] Takashimadaira Chuo Gen Hosp, Dept Clin Engn, Tokyo, Japan
[4] Takashimadaira Chuo Gen Hosp, Dept Nursing, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 05期
关键词：
hemodialysis; severe anemia; gastric bleeding; gastric hyperplastic polyp; proton-pump inhibitor; gastrin; CHRONIC KIDNEY-DISEASE; HELICOBACTER-PYLORI; SERUM GASTRIN; ACID SECRETION; RISK-FACTORS; THERAPY; DISAPPEARANCE; DISCONTINUATION; MANAGEMENT; JAPANESE;
D O I：
10.2169/internalmedicine.2091-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 90-year-old man on maintenance hemodialysis was admitted due to severe symptomatic anemia. Biopsies under esophagogastroduodenoscopy demonstrated that the cause of anemia was intermittent blood oozing from multiple gastric hyperplastic polyps. Even after successful eradication of Helicobacter pylori, he showed hypergastrinemia (480 pg/mL) owing to esomeprazole (proton-pump inhibitor) therapy for the past 4.5 years to treat reflux esophagitis. Seven months after we switched esomeprazole to famotidine (H2-receptor antagonist), those gastric polyps and anemia were remarkably ameliorated with lowered gastrin levels. This case indicates that long-term use of a proton-pump inhibitor triggers chronic hypergastrinemia, leading to gastric hyperplastic polyps and subsequent severe anemia.
引用
收藏
页码：649 / 657
页数：9
相关论文
共 50 条
  • [1] Disappearance of Gastric Hyperplastic Polyps after the Discontinuation of Proton Pump Inhibitor in a Patient with Liver Cirrhosis
    Yasugi, Kengo
    Haruma, Ken
    Kawanaka, Miwa
    Suehiro, Mitsuhiko
    Nakamura, Jun
    Urata, Noriyo
    Tanikawa, Tomohiro
    Oka, Takahito
    Monobe, Yasumasa
    Fujita, Takuya
    Kawamoto, Hirofumi
    CASE REPORTS IN GASTROENTEROLOGY, 2021, 15 (01) : 202 - 209
  • [2] Gastric Hyperplastic Polyps Associated with Proton Pump Inhibitor Use in a Case without a History of Helicobacter pylori Infection
    Miyamoto, Shuichi
    Kato, Mototsugu
    Matsuda, Kana
    Abiko, Satoshi
    Tsuda, Momoko
    Mizushima, Takeshi
    Yamamoto, Keiko
    Ono, Shoko
    Kudo, Takahiko
    Shimizu, Yuichi
    Hatanaka, Kanako C.
    Tsunematsu, Izumi
    Sakamoto, Naoya
    INTERNAL MEDICINE, 2017, 56 (14) : 1825 - 1829
  • [3] Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report
    Nakashima, Masatoshi
    Naoe, Hideaki
    Komohara, Yoshihiro
    Waki, Kotaro
    Miyamoto, Hideaki
    Sakai, Yoshinari
    Kojima, Toshiki
    Kanemitsu, Takao
    Yao, Kenshi
    Tanaka, Yasuhito
    IN VIVO, 2024, 38 (03): : 1465 - 1469
  • [4] Gastric Polyps in Long-Term Proton Pump Inhibitor Use: Identification of Risks and Characteristics
    Bouhairie, Malek Michael
    Elseblani, Racha
    Lakis, Remi
    Hallal, Mahmoud
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [5] Long-term use of proton-pump inhibitors and risk of gastric cancer: a review of the current evidence
    Cheung, Ka Shing
    Leung, Wai K.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [6] Enlargement of Gastric Hyperplastic Polyps Arising from Helicobacter heilmannii sensu strico-infected Mucosa after the Successful Eradication of Helicobacter pylori and the Long-Term Use of a Proton Pump Inhibitor
    Kurimoto, Masayuki
    Honjo, Hajime
    Yoshida, Saki
    Okai, Natsuki
    Otsuka, Yasuo
    Masuta, Yasuhiro
    Masaki, Sho
    Kamata, Ken
    Minaga, Kosuke
    Maenishi, Osamu
    Kudo, Masatoshi
    Watanabe, Tomohiro
    INTERNAL MEDICINE, 2024,
  • [7] Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy
    Holmberg, Dag
    Mattsson, Fredrik
    Xie, Shaohua
    Ness-Jensen, Eivind
    El-Serag, Hashem
    Lagergren, Jesper
    JOURNAL OF GASTROENTEROLOGY, 2022, 57 (12) : 942 - 951
  • [8] Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor
    Imai, Ryosuke
    Higuchi, Takakazu
    Morimoto, Masaya
    Koyamada, Ryosuke
    Okada, Sadamu
    INTERNAL MEDICINE, 2018, 57 (06) : 899 - 901
  • [9] Adverse effects of long-term proton-pump inhibitor therapy on adults
    Igaz Ivan
    Simonyi Gabor
    Balogh Sandor
    Szathmari Miklos
    ORVOSI HETILAP, 2018, 159 (19) : 735 - 740
  • [10] Why and how withdrawing treatment with proton pump inhibitor after long-term use?
    de Korwin, J. -D.
    REVUE DE MEDECINE INTERNE, 2012, 33 (08): : 417 - 420
12345